Nikolaus Möckelmann
Dr. med.
Nikolaus Möckelmann
  • Oberarzt
  • Wissenschaftlicher Mitarbeiter
  • Europäischer Facharzt für Hals-Nasen-Ohrenheilkunde, Kopf- und Halschirurgie (EBE ORL-HNS)
  • Facharzt für Hals-Nasen-Ohren-Heilkunde
  • Plastische Operationen
Arbeitsbereich

Standort

Hauptgebäude O10 , 2. Etage
Sprachen
Deutsch (Muttersprache)
Englisch

Fachgebiete

Tätigkeitsschwerpunkte

Publikationen

Zurück
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2012
  • 2009
Vor

Receptor tyrosine kinase MET as potential target of multi-kinase inhibitor and radiosensitizer sorafenib in HNSCC
Beizaei K, Gleißner L, Hoffer K, Bußmann L, Vu A, Steinmeister L, Laban S, Möckelmann N, Münscher A, Petersen C, Rothkamm K, Kriegs M
HEAD NECK-J SCI SPEC. 2019;41(1):208-215.

Analysis and Comparison of the 8th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System in Cutaneous and Oral Squamous Cell Cancer of the Head and Neck
Moeckelmann N, Ebrahimi A, Dirven R, Liu J, Low T, Gupta R, Ashford B, Ch'ng S, Palme C, Clark J
ANN SURG ONCOL. 2018;25(6):1730-1736.

Tumor thickness versus depth of invasion - Analysis of the 8th edition American Joint Committee on Cancer Staging for oral cancer
Dirven R, Ebrahimi A, Moeckelmann N, Palme C, Gupta R, Clark J
ORAL ONCOL. 2017;74:30-33.

Expression of Epithelial-Mesenchymal Transition Regulating Transcription Factors in Head and Neck Squamous Cell Carcinomas
Göppel J, Möckelmann N, Münscher A, Sauter G, Schumacher U
ANTICANCER RES. 2017;37(10):5435-5440.

Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines
Busch C, Becker B, Kriegs M, Gatzemeier F, Krüger K, Möckelmann N, Fritz G, Petersen C, Knecht R, Rothkamm K, Rieckmann T
ONCOTARGET. 2016;7(24):35832-35842.

Oncologic treatment landscape for head and neck squamous cell carcinoma: Treatment infrastructure in German-speaking countries
Kimmeyer J, Kurzweg T, Hoffmann T, Knecht R, Veit J, Möckelmann N, Münscher A, Laban S
HNO. 2016;64(7):494-500.

Ist Radio(chemo)therapie wirklich der zukünftige Standard für die Behandlung von Oropharynxkarzinomen?
Knecht R, Bussmann L, Möckelmann N, Lörincz B
HNO. 2016;64(4):221-6.

Palliative treatment standards for head and neck squamous cell carcinoma: Survey of clinical routine in German-speaking countries
Laban S, Kimmeyer J, Knecht R, Hoffmann T, Busch C, Veit J, Möckelmann N, Kurzweg T
HNO. 2016;64(7):487-93.

The impact of surgical technique on neck dissection nodal yield making a difference
Lörincz B, Langwieder F, Möckelmann N, Sehner S, Knecht R
EUR ARCH OTO-RHINO-L. 2016;273(5):1261–1267.

Neue Aspekte in der Therapie von Schilddrüsenkarzinomen: Highlights des ASCO-Kongresses 2016
Lörincz B, Simon C, Möckelmann N, Knecht R
HNO. 2016;64(10):736-40.

Molecular targeting in combination with platinum-based chemoradiation in head and neck cancer treatment
Möckelmann N, Kriegs M, Lörincz B, Busch C, Knecht R
HEAD NECK-J SCI SPEC. 2016;38(Suppl 1):E2173-81.

Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells
Möckelmann N, Rieckmann T, Busch C, Becker B, Gleißner L, Hoffer K, Omniczynski M, Steinmeister L, Laban S, Grénman R, Petersen C, Rothkamm K, Dikomey E, Knecht R, Kriegs M
ONCOTARGET. 2016;7(17):23542-51.

Feasibility and safety of transoral robotic surgery (TORS) for early hypopharyngeal cancer: a subset analysis of the Hamburg University TORS-trial
Lörincz B, Busch C, Möckelmann N, Knecht R
EUR ARCH OTO-RHINO-L. 2015;272(10):2993-2998.

Initial learning curve of single-incision transaxillary robotic hemi- and total thyroidectomy--A single team experience from Europe
Lörincz B, Busch C, Möckelmann N, Knecht R
INT SURG. 2015;18:118-22.

Automatic periodic stimulation of the vagus nerve during single-incision transaxillary robotic thyroidectomy: Feasibility, safety, and first cases
Lörincz B, Möckelmann N, Busch C, Hezel M, Knecht R
HEAD NECK-J SCI SPEC. 2015;38(3):482-485.

Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: Single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma
Lörincz B, Möckelmann N, Busch C, Knecht R
HEAD NECK-J SCI SPEC. 2015;37(11):1618-1624.

Two-Year Survival Analysis of 50 Consecutive Head and Neck Cancer Patients Treated with Transoral Robotic Surgery in a Single European Centre
Lörincz B, Möckelmann N, Busch C, Münscher A, Sehner S, Dalchow C, Knecht R
ANN SURG ONCOL. 2015;22:S1028-S1033.

Timing of neck dissection in patients undergoing transoral robotic surgery for head and neck cancer
Möckelmann N, Busch C, Münscher A, Knecht R, Lörincz B
EJSO-EUR J SURG ONC. 2015.

Robotic-assisted selective and modified radical neck dissection in head and neck cancer patients
Möckelmann N, Lörincz B, Knecht R
INT SURG. 2015;25:24-30.

Role of panendoscopy in identifying and managing risk of head and neck squamous cell carcinoma in routine follow-up: a retrospective clinical evaluation
Münscher A, Sehner S, Taleh J, Tribius S, Möckelmann N, Böttcher A, Gulati A, Dalchow C, Clauditz T, Knecht R
EUR ARCH OTO-RHINO-L. 2015;272(7):1769-75.

Single-incision transaxillary robotic total thyroidectomy for Graves' disease: improved feasibility and safety with novel robotic instrumentation
Lörincz B, Möckelmann N, Knecht R
EUR ARCH OTO-RHINO-L. 2014;271(12):3349-53.

Circulating tumor cells in head and neck cancer: clinical impact in diagnosis and follow-up
Möckelmann N, Laban S, Pantel K, Knecht R
EUR ARCH OTO-RHINO-L. 2014;271(1):15-21.

Therapie der rezidivierten und fernmetastasierten Plattenepithelkarzinome des Kopf-Hals-Bereichs: Highlights des ASCO-Meetings 2014
Zeller N, Busch C, Schafhausen P, Knecht R, Möckelmann N
HNO. 2014;62(11):787-92.

Current treatment options for recurrent/metastatic head and neck cancer: a post-ASCO 2011 update and review of last year's literature
Kurzweg T, Möckelmann N, Laban S, Knecht R
EUR ARCH OTO-RHINO-L. 2012;269(10):2157-67.

Current treatment options for recurrent/metastatic head and neck cancer: a post-ASCO 2011 update and review of last year's literature.
Kurzweg T, Möckelmann N, Laban S, Knecht R
EUR ARCH OTO-RHINO-L. 2012;269(10):2157-2167.

Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer.
Möckelmann N, von Schönfels W, Buch S, von Kampen O, Sipos B, Egberts J, Rosenstiel P, Franke A, Brosch M, Hinz S, Röder C, Kalthoff H, Fölsch U, Krawczak M, Schreiber S, Bröring C, Tepel J, Schafmayer C, Hampe J
BMC GASTROENTEROL. 2009;9:79.

Letzte Aktualisierung aus dem FIS: 24.06.2019 - 00:35 Uhr